Sunday, September 6, 2026

Can AI Speed Up Drug R&D?: PharmGen Science Teams With Polaris AI Pharma Across the Full Development Cycle

PharmGen Science partners with Polaris AI Pharma to enhance drug development using AI technologies and optimize R&D processes.

Is o3 Really That Smart? Experts Question OpenAI’s AI Scores

OpenAI's o3 AI model faces scrutiny over benchmark discrepancies, raising concerns about reliability in the AI industry.

Revolutionizing AI: How Korea’s NEO Model Understands the World Like Humans

South Korean researchers developed a next-gen AI model that theorizes reality through observation, enhancing understanding beyond predictions.

Tag: biotech industry

From Preclinical Development to Licensing: JNPMEDI Aims to Accelerate K-Biotech Growth With AI

JNPMEDI emphasizes the need for Korea's biotech sector to enhance global commercialization and reduce clinical trial costs using AI.

Top News

- Our Sponsors Ad -

Follow us